Working… Menu

Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02138383
Recruitment Status : Active, not recruiting
First Posted : May 14, 2014
Last Update Posted : July 8, 2019
Astellas Pharma Inc
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : December 15, 2016
Estimated Study Completion Date : December 2019